Evidence map›Paper›PMID 32330531›Full record

ArticleUrology2020

Managing Urology Consultations During COVID-19 Pandemic: Application of a Structured Care Pathway.

Alex Borchert, Lee Baumgarten, Deepansh Dalela, Marcus Jamil, Jeffrey Budzyn, Natalija Kovacevic, Grace Yaguchi, Isaac Palma-Zamora, Sara Perkins, Mahdi Bazzi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Telemedicine in Overactive Bladder Syndrome.Current bladder dysfunction reports · 2023
    Review
  3. COVID-19 in the hotspot of Metropolitan Detroit: A multi-faceted health system experience.The International journal of health planning and management · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Recommendations for skin cancer consultation and surgery during COVID-19 pandemic.Journal of the European Academy of Dermatology and Venereology : JEADV · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Alex BorchertVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Lee BaumgartenVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI. Electronic address: lbaumgarten1@gmail.com.
Deepansh DalelaVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Marcus JamilVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Jeffrey BudzynVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Natalija KovacevicVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Grace YaguchiVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Isaac Palma-ZamoraVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Sara PerkinsVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Mahdi BazziVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Phil WongVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Akshay SoodVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
James PeabodyVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Craig G RogersVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Ali DabajaVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Humphrey AtiemoVattikutti Urology Institute, Henry Ford Hospital, Detroit, MI.
Henry Ford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe and evaluate a risk-stratified triage pathway for inpatient urology consultations during the SARS-CoV-2 (COVID-19) pandemic. This pathway seeks to outline a urology patient care strategy that reduces the transmission risk to both healthcare providers and patients, reduces the healthcare burden, and maintains appropriate patient care. MATERIALS AND

methodsConsultations to the urology service during a 3-week period (March 16 to April 2, 2020) were triaged and managed via one of 3 pathways: Standard, Telemedicine, or High-Risk. Standard consults were in-person consults with non COVID-19 patients, High-Risk consults were in-person consults with COVID-19 positive/suspected patients, and Telemedicine consults were telephonic consults for low-acuity urologic issues in either group of patients. Patient demographics, consultation parameters and consultation outcomes were compared to consultations from the month of March 2019. Categorical variables were compared using Chi-square test and continuous variables using Mann-Whitney U test. A P value <.05 was considered significant.

resultsBetween March 16 and April 2, 2020, 53 inpatient consultations were performed. By following our triage pathway, a total of 19/53 consultations (35.8%) were performed via Telemedicine with no in-person exposure, 10/53 consultations (18.9%) were High-Risk, in which we strictly controlled the urology team member in-person contact, and the remainder, 24/53 consultations (45.2%), were performed as Standard in-person encounters. COVID-19 associated consultations represented 18/53 (34.0%) of all consultations during this period, and of these, 8/18 (44.4%) were managed successfully via Telemedicine alone. No team member developed COVID-19 infection.

conclusionDuring the COVID-19 pandemic, most urology consultations can be managed in a patient and physician safety-conscious manner, by implementing a novel triage pathway.

Indexed as

BetacoronavirusUrologyAdultAgedCoronavirus InfectionsCOVID-19Critical PathwaysFemaleHospitalizationHumansMaleMiddle AgedPandemicsPneumonia, ViralReferral and ConsultationRisk Assessment

Identifiers

PMID32330531
PMCPMC7172673
OpenAlexW3016400817

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.